Nanomaterials for photohyperthermia: A review

Current Pharmaceutical Design

Volumn 19, Issue 37, 2013, Pages 6622-6634

  Fang, Jonathan ^a   Chen, Yu Chie ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Carbon nanotubes; Gold nanoparticles; Magnetic nanoparticles; Nanomaterials; Photohyperthermia; Photothermal agents; Theranostics

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON NANOTUBE; CISPLATIN; COPPER DERIVATIVE; COPPER SELENIDE; COPPER SULFIDE; DOXORUBICIN; FOLIC ACID; GOLD NANOPARTICLE; IRON OXIDE; MAGNETIC NANOPARTICLE; MULTI WALLED NANOTUBE; NANOMATERIAL; NANOROD; NANOSHELL; PACLITAXEL; SINGLE WALLED NANOTUBE; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; APOPTOSIS; CANCER CELL; CELL VIABILITY; COVALENT BOND; DRUG CONJUGATION; HUMAN; MAGNETIC FIELD; NONHUMAN; PARTICLE SIZE; PHOTOTHERMAL THERAPY; PHYSICAL MEDICINE; PRIORITY JOURNAL; REVIEW; SURFACE PLASMON RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VOLUME; UTERINE CERVIX CANCER;

ANIMALS; HUMANS; HYPERTHERMIA, INDUCED; NANOSTRUCTURES; NEOPLASMS; PHOTOTHERAPY;

EID: 84887890371     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319370006     Document Type: Review

References (115)

1. Doane TL, Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev 2012; 41: 2885-911.
2. Pitsillides CM, Joe EK, Wei X, Anderson RR, Lin CP. Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J 2003; 84(6): 4023-32.
3. Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002; 6: 319-27.
4. Lassalle V, Ferreira ML. PLA Nano-and microparticles for drug delivery: an overview of the methods of preparation. Macromol Biosci 2007; 7: 767-83.
5. Chan JM, Zhang L, Yuet KP, et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 2009; 30: 1627-34.
6. Chawla JS, Amiji MM. Biodegradable poly([-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 2002; 249: 127-38.
7. Gupta U, Jain NK. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting. Adv Drug Deliv Rev 2010; 62: 478-90.
8. He Q, Shi J. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem 2011; 21: 5845-55.
9. Barbe C, Bartlett J, Kong L, et al. Silica particles: a novel drugdelivery system. Adv Mater 2004; 16: 1959-66.
10. van der Zee J. Heating the patient: a promising approach? Ann Oncol 2002; 13: 1173-1184.
11. Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3: 487-97.
12. Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001; 17: 1-18.
13. Day ES, Morton JG, West JL. Nanoparticles for thermal cancer therapy. J Biomech Eng 2009; 131: (074001-1)-(074001-5).
14. Moroz P, Jones SK, Gray BN. Status of hyperthermia in the treatment of advanced liver cancer. J Surg Oncol 2001; 77: 259-69.
15. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res 1979; 39: 2264-8.
16. Christophi C, Winkworth A, Muralihdaran V, Evans P. The treatment of malignancy by hyperthermia. Surg Oncol 1999; 7: 83-90.
17. Moyer HR, Delman KA. The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia 2008; 24(3): 251-61.
18. Zhao QL, Fujiwara Y, Kondo T. Mechanism of cell death induction by nitroxide and hyperthermia. Free Radic Biol Med 2006; 40: 1131-43.
19. Takahashi I, Emi Y, Hasuda S, Kakeji Y, Maehara Y, Sugimachi K. Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors. Surgery 2002; 131: S78-S84.
20. Horsman MR, Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol 2007; 19: 418-26.
21. Franckena M, Fatehi D, de Bruijne M, et al. Hyperthermia doseeffect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer 2009; 45: 1969-78.
22. Kikumori T, Kobayashi T, Sawaki M, Imai T. Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes. Breast Cancer Res Treat 2009; 113: 435-41.
23. Baronzio G, Gramaglia A, Fiorentini G. Current role and future perspectives of hyperthermia for prostate cancer treatment. In vivo 2009; 23: 143-6.
24. Stein U, Rau B, Wust P, Walther W, Schlag PM. Hyperthermia for treatment of rectal cancer: evaluation for induction of multidrug resistance gene (mdr1) expression. Int J Cancer 1999; 80: 5-12.
25. van de Vaart PJM, van der Vange N, Zoetmulder FAN, et al. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct forma tion in patients and ovarian cancer cell lines. Eur J Cancer 1998; 34: 148-54.
26. Matsumine A, Takegami K, Asanuma K, et al. A novel hyperthermia treatment for bone metastases using magnetic materials. Int J Clin Oncol 2011; 16: 101-8.
27. Owens SD, Gasper PW. Hyperthermic therapy for HIV infection. Med Hypotheses 1995; 44: 235-42.
28. Steger AC, Lees WR, Walmsley K, Bown SG. Interstitial laser hyperthermia: a new approach to local destruction of tumours. Br Med J 1989; 299: 362-5.
29. Gannon CJ, Patra CR, Bhattacharya R, Mukherjee P, Curley SA. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J Nanobiotechnology 2008; 6: 1-9.
30. Chen X, Diederich CJ, Wootton JH, Pouliot J, Hsu IC. Optimisation-based thermal treatment planning for catheter-based ultrasound hyperthermia. Int J Hyperthermia 2010; 26(1): 39-55.
31. Li JL, Gu M. Gold-nanoparticle-enhanced cancer photothermal therapy. IEEE J Sel Top Quantum Electron 2010; 16: 989-96.
32. Alkilany AM, Thompson LB, Boulos SP, Sisco PN, Murphy CJ. Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv Drug Deliv Rev 2012; 64: 190-9.
33. Choi WL, Sahu A, Kim YH, Tae G. Photothermal cancer therapy and imaging based on gold nanorods. Ann Biomed Eng 2012; 40: 534-46.
34. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 2008; 23: 217-28.
35. Dickerson EB, Dreaden EC, Huang X, et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 2008; 269: 57-66.
36. Sperling RA, Gil PR, Zhang F, Zanella M, Parak WJ. Biological applications of gold nanoparticles. Chem Soc Rev 2008; 37: 1896-908.
37. Liao H, Hafner JH. Gold nanorod bioconjugates. Chem Mater 2005; 17: 4636-41.
38. Bardhan R, Chen W, Bartels M, et al. Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo. Nano Lett 2010; 10: 4920-8.
39. El-Sayed IH, Huang X, El-Sayed MA. Selective laser photothermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 2006; 239: 129-35.
40. Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006; 128: 2115-20.
41. Loo C, Lowery A, Halas N, West J, Drezek R. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 2005; 5: 709-11.
42. Zharov VP, Galitovskaya EN, Johnson C, Kelly T. Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: potential for cancer therapy. Lasers Surg Med 2005; 37: 219-26.
43. Zharov VP, Letfullin RR, Galitovskaya EN. Microbubblesoverlapping mode for laser killing of cancer cells with absorbing nanoparticle clusters. J Phys D Appl Phys 2005; 38: 2571-81.
44. Jin H, Yang P, Cai J, Wang J, Liu M. Photothermal effects of folate-conjugated Au nanorods on HepG2 cells. Appl Microbiol Biotechnol 2012; 94: 1199-208.
45. Ray PC, Khan SA, Singh AK, Senapati D, Fan Z. Nanomaterials for targeted detection and photothermal killing of bacteria. Chem Soc Rev 2012; 41: 3193-209.
46. Zharov VP, Mercer KE, Galitovskaya EN, Smeltzer MS. Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. Biophys J 2006; 90: 619-27.
47. Khan SA, Singh AK, Senapati D, Fan Z, Ray PC. Bio-conjugated popcorn shaped gold nanoparticles for targeted photothermal killing of multiple drug resistant Salmonella DT104. J Mater Chem 2011; 21: 17705-9.
48. Huang WC, Tsai PJ, Chen YC. Functional gold nanoparticles as photothermal agents for selective-killing of pathogenic bacteria. Nanomedicine 2007; 2(6): 777-87.
49. Norman RS, Stone JW, Gole A, Murphy CJ, Sabo-Attwood TL. Targeted photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods. Nano Lett 2008; 8: 302-6.
50. Fan Z, Shelton M, Singh AK, Senapati D, Khan SA, Ray PC. Multifunctional plasmonic shell-magnetic core nanoparticles for targeted diagnostics, isolation, and photothermal destruction of tumor cells. ACS Nano 2012; 6: 1065-73.
51. Liu X, Tao H, Yang K, Zhang S, Lee ST, Liu Z. Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomaterials 2011; 32: 144-51.
52. Lal S, Clare SE, Halas NJ. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc Chem Res 2008; 41: 1842-51.
53. Cole AJ, Yang VC, David AE. Cancer theranostics: the rise of the targeted magnetic nanoparticles. Trends Biotechnol 2011; 29: 323-32.
54. Kelkar SS, Reineke TM. Theranostics: combining imaging and therapy. Bioconjug Chem 2011; 22: 1879-903.
55. 4/alumina core/shell MNPs as photothermal agents for targeted hyperthermia of nosocomial and antibiotic-resistant bacteria. Nanomedicine 2011; 6(8): 1353-63.
56. Moon HK, Lee SH, Choi HC. In vivo near-infrared mediated tumor destruction by photothermal effect of carbon nanotubes. ACS Nano 2009; 3: 3707-13.
57. Faraday M. Experimental relations of gold (and other metals) to light. Philos Trans R Soc London 1857; 147: 145-81.
58. Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951; 11: 55-75.
59. Brust M, Walker M, Bethell D, Schiffrin DJ, Whyman R. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system. J Chem Soc Chem Commun 1994; 7: 801-2.
60. Everts M, Saini V, Leddon JL, et al. Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy. Nano Lett 2006; 6: 587-91.
61. Tshikudo TR, Wang Z, Brust M. Biocompatible gold nanoparticles. Mater Sci Technol 2004; 20: 980-4.
62. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photothermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 2004; 209: 171-6.
63. Khlebtsov B, Zharov V, Melnikov A, Tuchin V, Khlebtsov N. Optical amplification of photothermal therapy with gold nanoparticles and nanoclusters. Nanotechnology 2006; 17: 5167-79.
64. Day ES, Bickford LR, Slater JH, Riggall NS, Drezek RA, West JL. Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer. Int J Nanomedicine 2010; 5: 445-54.
65. Hirsch LR, Stafford RJ, Bankson JA, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A 2003; 100: 13549-54.
66. Zhang G, Sun X, Jasinski J, Patel D, Gobin AM. Gold/chitosan nanocomposites with specific near infrared absorption for photothermal therapy applications. J Nanomater 2012; 853416: 1-9.
67. Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett 2007; 7: 1929-34.
68. Hauck TS, Jennings TL, Yatsenko T, Kumaradas JC, Chan WCW. Enhancing the toxicity of cancer chemotherapeutics with gold nanorod hyperthermia. Adv Mater 2008; 20: 3832-8.
69. Kennedy LC, Bickford LR, Lewinski NA, et al. A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Small 2011; 7: 169-83.
70. Khlebtsov BN, Panfilova EV, Terentyuk GS, Maksimova IL, Ivanov AV, Khlebtsov NG. Plasmonic nanopowders for photothermal therapy of tumors. Langmuir 2012; 28: 8994-9002.
71. Jana NR, Gearheart L, Murphy CJ. Wet chemical synthesis of high aspect ratio cylindrical gold nanorods. J Phys Chem B 2001; 105: 4065-7.
72. Link S, Mohamed MB, El-Sayed MA. Simulation of the optical absorption spectra of gold nanorods as a function of their aspect ratio and the effect of the medium dielectric constant. J Phys Chem B 1999; 103: 3073-7.
73. van der Zande BMI, Bohmer MR, Fokkink LGJ, Schonenberger C. Colloidal dispersions of gold rods: synthesis and optical properties. Langmuir 2000; 16: 451-8.
74. Hartmann LC, Keeney GL, Lingle WL, et al. Folate receptor overexpression is associated with poor outcome in breast cancer. Int J Cancer 2007; 121: 938-42.
75. Toffoli G, Cernigoi C, Russo A, Gallo A, Bagnoli M, Boiocchi M. Overexpression of folate binding protein in ovarian cancers. Int J Cancer 1997; 74: 193-8.
76. Wang X, Li J, Wang Y, et al. A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model. ACS Nano 2011; 5: 6184-94.
77. 4 nanoparticle "nano-pearl-necklaces" for simultaneous targeting, dual-mode imaging, and photothermal ablation of cancer cells. Angew Chem Int Ed 2009; 48: 2759-63.
78. Ke H, Wang J, Dai Z, et al. Bifunctional gold nanorod-loaded polymeric microcapsules for both contrast-enhanced ultrasound imaging and photothermal therapy. J Mater Chem 2011; 21: 5561-4.
79. Oldenburg SJ, Averitt RD, Westcott SL, Halas NJ. Nanoengineering of optical resonances. Chem Phys Lett 1998; 288: 243-7.
80. Averitt RD, Westcott SL, Halas NJ. Linear optical properties of gold nanoshells. J Opt Soc Am B 1999; 16: 1824-1832.
81. Larson TA, Bankson J, Aaron J, Sokolov K. Hybrid plasmonic magnetic nanoparticles as molecular specific agents for MRI/optical imaging and photothermal therapy of cancer cells. Nanotechnology 2007; 18: 325101 (8pp).
82. 4@Au nanoeggs as photothermal agents for selective killing of nosocomial and antibiotic-resistant bacteria. Small 2009; 5: 51-6.
83. Vigderman L, Manna P, Zubarev ER. Quantitative replacement of cetyl trimethylammonium bromide by cationic thiol ligands on the surface of gold nanorods and their extremely large uptake by cancer cells. Angew Chem Int Ed 2012; 51: 636-41.
84. Puvanakrishnan P, Park J, Chatterjee D, Krishnan S, Tunnell JW. In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy. Int J Nanomedicine 2012; 7: 1251-8.
85. Kumar CSSR, Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Deliv Rev 2011; 63: 789-808.
86. Chertok B, Moffat BA, David AE, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 2008; 29: 487-96.
87. Jain TK, Richey J, Strand M, Leslie-Pelecky DL, Flask CA, Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 2008; 29: 4012-21.
88. 4 magnetic nanoparticles. Biochem Eng J 2008; 42: 290-300.
89. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108: 2064-110.
90. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005; 26: 3995-4021.
91. Liao MY, Lai PS, Yu HP, Lin HP, Huang CC. Innovative ligandassisted synthesis of NIR-activated iron oxide for cancer theranostics. Chem Commun 2012; 48: 5319-21.
92. Vardarajan V, Gu L, Kanneganti, Mohanty SK, Koymen AR. Photothermal therapy of cancer cells using magnetic carbon nanoparticles. Proceedings of the SPIE Conference on Optical Interactions with Tissue and Cells XXII, San Francisco, CA, Jan. 24-26, 2011; pp. 78970Z-1-78970Z-7.
93. Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 1981; 17: 1247-8.
94. Iijima S. Helical microtubules of graphitic carbon. Nature 1991; 354: 56-8.
95. Ajayan PM, Zhou OZ. Applications of carbon nanotubes. Topics Appl Phys 2001; 80: 391-425.
96. Yang W, Thordarson P, Gooding JJ, Ringer SP, Braet F. Carbon nanotubes for biological and biomedical applications. Nanotechnology 2007; 18: 412001 (12pp).
97. Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun 2005; 5: 571-7.
98. Kam NWS, O'Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci U S A 2005; 102: 11600-5.
99. Burke A, Ding X, Singh R, et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc Natl Acad Sci U S A 2009; 106: 12897-902.
100. Ghosh S, Dutta S, Gomes E, et al. Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano 2009; 3: 2667-73.
101. Marches R, Chakravarty P, Musselman IH, et al. Specific thermal ablation of tumor cells using single-walled carbon nanotubes targeted by covalently-coupled monoclonal antibodies. Int J Cancer 2009; 125: 2970-7.
102. Wang CH, Chiou SH, Chou CP, Chen YC, Huang YJ, Peng CA. Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody. Nanomedicine 2011; 7: 69-79.
103. Liu X, Tao H, Yang K, Zhang S, Lee ST, Liu Z. Optimization of surface chemistry on single-walled carbon nanotubes for in vivo photothermal ablation of tumors. Biomaterials 2011; 32: 144-51.
104. Huang N, Wang H, Zhao J, Lui H, Korbelik M, Zeng H. Single-Wall Carbon Nanotubes Assisted Photothermal Cancer Therapy: Animal Study With a Murine Model of Squamous Cell Carcinoma. Lasers Surg Med 2010; 42: 638-48.
105. Zhou F, Wu S, Song S, Chen WR, Resasco DE, Xing D. Antitumor immunologically modified carbon nanotubes for photothermal therapy. Biomaterials 2012; 33: 3235-42.
106. Burke AR, Singh RN, Carroll DL, et al. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials 2012; 33: 2961-70.
107. Song S, Zhou F, Nordquist RE, Carubelli R, Liu H, Chen WR. Glycated chitosan as a new non-toxic immunological stimulant. Immunopharmacol Immunotoxicol 2009; 31(2): 202-8.
108. Li Y, Lu W, Huang Q, Huang M, Li C, Chen W. Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine 2010; 5(8): 1161-71.
109. Hessel CM, Pattani VP, Rasch M, et al. Copper selenide nanocrystals for photothermal therapy. Nano Lett 2011; 11: 2560-6.
110. 2 Nanotubes as a therapeutic agent for cancer thermotherapy. Photochem Photobiol 2010; 86: 981-9.
111. Yang J, Lee J, Kang J, et al. Smart drug-loaded polymer gold nanoshells for systemic and localized therapy of human epithelial cancer. Adv Mater 2009; 21: 4339-42.
112. Cheng FY, Su CH, Wu PC, Yeh CS. Multifunctional polymeric nanoparticles for combined chemotherapeutic and near-infrared photothermal cancer therapy in vitro and in vivo. Chem Commun 2010; 46: 3167-9.
113. Young JK, Figueroa ER, Drezek RA. Tunable nanostructures as photothermal theranostic agents. Ann Biomed Eng 2012; 40: 438-59.
114. Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004; 4: 11-8.
115. Nanospectra Biosciences, Inc., Pilot study of AuroLase™ therapy in refractory and/or recurrent tumors of the head and neck. ClinicalTrials. gov: A service of the U. S. National Institutes of Health [cited 2012 Dec 28]. Available from: http://clinicaltrials. gov/ct2/show/study/NCT00848042?term=auros hells.